20/20 Capital Management’s AbbVie ABBV Stock Holding History

20/20 Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$513K	Buy	4,555 +536	+13%	+$60.4K	0.13%	100
2021 Q1	$435K	Buy	4,019 +205	+5%	+$21.9K	0.13%	107
2020 Q4	$395K	Buy	3,814 +222	+6%	+$21.3K	0.12%	118
2020 Q3	$315K	Sell	3,592 -30	-0.8%	-$2.82K	0.12%	117
2020 Q2	$337K	Buy	3,622 +146	+4%	+$12.9K	0.13%	101
2020 Q1	$293K	Buy	3,476 +266	+8%	+$22.7K	0.13%	112
2019 Q4	$280K	Buy	+3,210	New	+$266K	0.11%	123

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

20/20 Capital Management's ABBV Position: Q2 2021 in Review

20/20 Capital Management increased its AbbVie (ABBV) stake by 13% in Q2 2021, buying an estimated $60.4K and bringing the position to 4,555 shares worth $513K. The position accounts for 0.13% of the portfolio, ranked #100.

20/20 Capital Management first reported a position in ABBV in Q4 2019 and has held it in 7 quarters since. 2,677 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

20/20 Capital Management held 4,555 shares of AbbVie worth $513K as of Q2 2021.
20/20 Capital Management bought 536 AbbVie shares in Q2 2021, an estimated $60.4K.
AbbVie made up 0.13% of 20/20 Capital Management's portfolio in Q2 2021, its #100 holding.
20/20 Capital Management first reported a position in AbbVie in Q4 2019 and has held it in 7 quarters since.
2,677 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on 20/20 Capital Management's 13F filing for Q2 2021, filed 12 Jul 2021.